Servier is already in the process of transforming ... dramatically expanding the eligible patient population for the drug. It also allocates 50% of its internal R&D budget to cancer candidates ...

Agios hit a setback for Tibsovo in Europe this year however after the EMA rejected the marketing application for the drug. Servier is paying $1.8 billion upfront for the oncology assets, with the ...

Servier’s decision to exit a Parkinson’s ... % pay cuts as part of the push to reduce spending. GSK offloads French drug discovery site, commits $40M to support transition OPM teased ...

Artificial intelligence (AI) has taken the biotech industry by storm, allowing companies to speed up the drug discovery process while also making it more cost-effective. With so many companies in the ...

Novartis has terminated a phase 2 trial evaluating an investigational ADAMTS-5 inhibitor for patients with osteoarthritis ...

It is indicated for patients with a susceptible IDH1 mutation, which is identified through an FDA-approved test. Currently, TIBSOVO is approved for the treatment of newly diagnosed acute myeloid ...

Levies on Americans’ daily prescriptions and other medicines could raise costs, spur rationing and lead to shortages of critical drugs. By Rebecca Robbins President Trump’s decision to move a ...

The state of California is now selling the opioid reversal drug Narcan to individuals online. The program, which began in 2024, is meant to make the life-saving overdose medication less expensive ...

Chelsea Handler is no rookie when it comes to taking or sharing drugs with her celebrity pals. The “Fun Size” comedian opened up about her use of “natural drugs” and “micro-dosing ...

In his first major action on health care costs this term, President Donald Trump issued a multi-part executive order on Tuesday aimed at lowering drug prices and reducing costs for Medicare.